Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

  1. Twelves, C.
  2. Scheithauer, W.
  3. Mckendrick, J.
  4. Seitz, J.-F.
  5. Van Hazel, G.
  6. Wong, A.
  7. Díaz-Rubio, E.
  8. Gilberg, F.
  9. Cassidy, J.
Zeitschrift:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Datum der Publikation: 2012

Ausgabe: 23

Nummer: 5

Seiten: 1190-1197

Art: Artikel

DOI: 10.1093/ANNONC/MDR366 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus